Study | Irradiated liver metastases (n) | Nominal total dose/single dose (Gy) | BED2 (Gy) | Lesion size (ccm) | Median FU (months) | 1-year LC rate (%) |
---|---|---|---|---|---|---|
Katz et al., 2007 [21] | 69 | 30-55/2-6 | 40-73* | 0.1-950* | 14.5 | 76 |
McCammon et al., 2009 [5] | 81 | 3 dose levels: | 3 levels*: | 2.8-370 | 8.2 | |
1.) < 36/12 | 1.) 39 | 1.) 40 | ||||
2.) 36-54/12-18 | 2.) 39-58 | 2.) 88 | ||||
3.) 54/18 | 3.) 58 | 3.) 100 | ||||
Milano et al., 2008 [22] | 121 | 10-20/10-20 | 16-50 | 0.2-422 | Not stated | 57 |
Goodmann et al., 2010 [23] | 40 | 18-30/18-30 | 42-100* | 0.8-146 | 17 | 77 |
Iwata et al., 2010 [24] | 12 | 50-55/5-5.5 | 62-71* | 0.9-22* | 14.5 | 86 |
Rusthoven et al., 2009 [25] | 63 | 36-60/12-20 | 66-150* | <113* | 16 | 95 |
Lee et al., 2009 [26] | 68 | 42-60/7-10 | 59-100* | 1.19-3000 | 10.8 | 71 |
Current series JBH et al. | 22 | 24-60/24-12 | 44-150 | 11-419 | 12 | 57 |